125 related articles for article (PubMed ID: 21482467)
1. Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor.
Young RJ; Alderton W; Angell AD; Beswick PJ; Brown D; Chambers CL; Crowe MC; Dawson J; Hamlett CC; Hodgson ST; Kleanthous S; Knowles RG; Russell LJ; Stocker R; Woolven JM
Bioorg Med Chem Lett; 2011 May; 21(10):3037-40. PubMed ID: 21482467
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a series of aminopiperidines as novel iNOS inhibitors.
Le Bourdonnec B; Leister LK; Ajello CA; Cassel JA; Seida PR; O'Hare H; Gu M; Chu GH; Tuthill PA; DeHaven RN; Dolle RE
Bioorg Med Chem Lett; 2008 Jan; 18(1):336-43. PubMed ID: 18024030
[TBL] [Abstract][Full Text] [Related]
3. 1,3,4-Thiadiazole derivatives as selective inhibitors of iNOS versus nNOS: Synthesis and structure-activity dependence.
López-Cara LC; Carrión MD; Entrena A; Gallo MA; Espinosa A; López A; Escames G; Acuña-Castroviejo D; Camacho ME
Eur J Med Chem; 2012 Apr; 50():129-39. PubMed ID: 22336385
[TBL] [Abstract][Full Text] [Related]
4. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.
Collins JL; Shearer BG; Oplinger JA; Lee S; Garvey EP; Salter M; Duffy C; Burnette TC; Furfine ES
J Med Chem; 1998 Jul; 41(15):2858-71. PubMed ID: 9667974
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase.
Maccallini C; Patruno A; Besker N; Alì JI; Ammazzalorso A; De Filippis B; Franceschelli S; Giampietro L; Pesce M; Reale M; Tricca ML; Re N; Felaco M; Amoroso R
J Med Chem; 2009 Mar; 52(5):1481-5. PubMed ID: 19203270
[TBL] [Abstract][Full Text] [Related]
6. Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors.
López Cara LC; Camacho ME; Carrión MD; Tapias V; Gallo MA; Escames G; Acuña-Castroviejo D; Espinosa A; Entrena A
Eur J Med Chem; 2009 Jun; 44(6):2655-66. PubMed ID: 19117642
[TBL] [Abstract][Full Text] [Related]
7. The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
Strub A; Ulrich WR; Hesslinger C; Eltze M; Fuchss T; Strassner J; Strand S; Lehner MD; Boer R
Mol Pharmacol; 2006 Jan; 69(1):328-37. PubMed ID: 16223957
[TBL] [Abstract][Full Text] [Related]
8. Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III).
Carrión MD; López Cara LC; Camacho ME; Tapias V; Escames G; Acuña-Castroviejo D; Espinosa A; Gallo MA; Entrena A
Eur J Med Chem; 2008 Nov; 43(11):2579-91. PubMed ID: 18325637
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 4,5-dihydro-1H-pyrazole derivatives as potential nNOS/iNOS selective inhibitors. Part 2: Influence of diverse substituents in both the phenyl moiety and the acyl group.
Carrión MD; Chayah M; Entrena A; López A; Gallo MA; Acuña-Castroviejo D; Camacho ME
Bioorg Med Chem; 2013 Jul; 21(14):4132-42. PubMed ID: 23735830
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of inducible nitric oxide synthase by derivatives of acetamidine.
Maccallini C; Patruno A; Ammazzalorso A; De Filippis B; Fantacuzzi M; Franceschelli S; Giampietro L; Masella S; Tricca ML; Amoroso R
Med Chem; 2012 Nov; 8(6):991-5. PubMed ID: 22741778
[TBL] [Abstract][Full Text] [Related]
11. Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models.
Bonnefous C; Payne JE; Roppe J; Zhuang H; Chen X; Symons KT; Nguyen PM; Sablad M; Rozenkrants N; Zhang Y; Wang L; Severance D; Walsh JP; Yazdani N; Shiau AK; Noble SA; Rix P; Rao TS; Hassig CA; Smith ND
J Med Chem; 2009 May; 52(9):3047-62. PubMed ID: 19374401
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine.
Fantacuzzi M; Maccallini C; Lannutti F; Patruno A; Masella S; Pesce M; Speranza L; Ammazzalorso A; De Filippis B; Giampietro L; Re N; Amoroso R
ChemMedChem; 2011 Jul; 6(7):1203-6. PubMed ID: 21567968
[No Abstract] [Full Text] [Related]
13. BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b]pyridine) is an NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase.
Tiso M; Strub A; Hesslinger C; Kenney CT; Boer R; Stuehr DJ
Mol Pharmacol; 2008 Apr; 73(4):1244-53. PubMed ID: 18178668
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, bioevaluation and docking studies of new imidamide derivatives as nitric oxide synthase inhibitors.
Arias F; Franco-Montalban F; Romero M; Carrión MD; Camacho ME
Bioorg Med Chem; 2021 Aug; 44():116294. PubMed ID: 34218000
[TBL] [Abstract][Full Text] [Related]
15. 1H-pyrazole-1-carboxamidines: new inhibitors of nitric oxide synthase.
Lee Y; Martásek P; Roman LJ; Silverman RB
Bioorg Med Chem Lett; 2000 Dec; 10(24):2771-4. PubMed ID: 11133088
[TBL] [Abstract][Full Text] [Related]
16. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
[TBL] [Abstract][Full Text] [Related]
17. 1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation.
Wei RG; Adler M; Davey D; Ho E; Mohan R; Polokoff M; Tseng JL; Whitlow M; Xu W; Yuan S; Phillips G
Bioorg Med Chem Lett; 2007 May; 17(9):2499-504. PubMed ID: 17368901
[TBL] [Abstract][Full Text] [Related]
18. Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.
Maccallini C; Di Matteo M; Gallorini M; Montagnani M; Graziani V; Ammazzalorso A; Amoia P; De Filippis B; Di Silvestre S; Fantacuzzi M; Giampietro L; Potenza MA; Re N; Pandolfi A; Cataldi A; Amoroso R
Eur J Med Chem; 2018 May; 152():53-64. PubMed ID: 29689474
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing.
Guo JS; Cho CH; Wang JY; Koo MW
Eur J Pharmacol; 2006 May; 536(3):301-8. PubMed ID: 16600210
[TBL] [Abstract][Full Text] [Related]
20. The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).
Cheshire DR; Åberg A; Andersson GM; Andrews G; Beaton HG; Birkinshaw TN; Boughton-Smith N; Connolly S; Cook TR; Cooper A; Cooper SL; Cox D; Dixon J; Gensmantel N; Hamley PJ; Harrison R; Hartopp P; Käck H; Leeson PD; Luker T; Mete A; Millichip I; Nicholls DJ; Pimm AD; St-Gallay SA; Wallace AV
Bioorg Med Chem Lett; 2011 Apr; 21(8):2468-71. PubMed ID: 21398123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
